Most people on semaglutide (the active ingredient in Ozempic) lose between 5% and 15% of their body weight, with some losing more. For someone starting at 220 pounds, that translates to roughly 11 to 33 pounds. The exact amount depends on your dose, whether you have type 2 diabetes, how long you stay on the medication, and how much you change your eating and exercise habits alongside it.
Average Weight Loss by the Numbers
A large meta-analysis of eight clinical trials involving over 4,500 patients without diabetes found that semaglutide produced an average body weight reduction of about 10%, or roughly 23 pounds, compared to placebo. Results across individual studies ranged from about 5% to over 16% of starting body weight lost. That’s a wide spread, and it reflects real variation between people.
What stands out is how many people hit meaningful milestones. Compared to placebo, participants on semaglutide were three times more likely to lose at least 5% of their body weight, nearly five times more likely to lose 10%, and about eight times more likely to lose 15%. A smaller but notable group lost 20% or more of their starting weight.
If you have type 2 diabetes, expect somewhat lower numbers. In the SUSTAIN FORTE trial, which studied Ozempic specifically in people with type 2 diabetes already taking metformin, average weight loss ranged from about 9 to 14 pounds over 40 weeks. Diabetes changes the body’s metabolic response to the drug, and weight loss tends to be more modest than in people using semaglutide purely for obesity.
What the First Few Months Look Like
Weight loss on semaglutide isn’t instant, and the first month is mostly about adjusting to the medication. In the STEP 1 trial, participants on the higher dose lost an average of 3.8% of their body weight after just four weeks. For a 200-pound person, that’s about 7 to 8 pounds. Some people lose more, some less, and early results don’t always predict long-term outcomes.
By 12 weeks, the curve steepens. At the three-month mark in the same trial, average weight loss reached 9.6% of baseline body weight, compared to 2.8% in the placebo group. That’s when many people start to feel a real difference in how their clothes fit and how they move through daily life. The medication is typically escalated in dose during this period, starting low and increasing every four weeks to reduce nausea and other digestive side effects.
Peak weight loss generally occurs around 60 to 68 weeks (roughly 15 to 17 months) of continuous use. After that, weight tends to stabilize on a plateau rather than continuing to drop.
How Ozempic Actually Reduces Weight
Semaglutide mimics a hormone your gut naturally releases after eating. This hormone works on three fronts simultaneously. It signals satiety centers in the brain, making you feel full sooner and reducing the mental pull toward food between meals. It slows how quickly your stomach empties, so meals sit with you longer and you’re less inclined to snack. And it helps regulate blood sugar by prompting insulin release, which smooths out the energy crashes that can trigger overeating.
The stomach-slowing effect is strongest right after your first dose and fades somewhat over time as your body adjusts. The appetite suppression, however, tends to persist as long as you’re on the medication. Most people describe it as a quieting of “food noise,” that constant background hum of thinking about what to eat next.
Dose Matters, but Not as Much as You’d Think
Ozempic is available in 0.25 mg, 0.5 mg, 1 mg, and 2 mg doses. You start at the lowest dose and work up. In the SUSTAIN FORTE trial comparing 1 mg to 2 mg in people with type 2 diabetes, the higher dose produced somewhat more weight loss (closer to 14 pounds versus 9 pounds over 40 weeks). But the 2 mg dose also came with a higher rate of gastrointestinal side effects: 34% of people on the higher dose experienced them compared to about 31% on the lower dose.
The jump from 1 mg to 2 mg doesn’t double your results. For many people, the added benefit is modest enough that their doctor may keep them at 1 mg if they’re tolerating it well and seeing progress. It’s worth noting that the higher doses approved specifically for weight management (sold as Wegovy rather than Ozempic) go up to 2.4 mg, which is where the largest clinical trial results come from.
What Happens When You Stop
This is the part most people don’t want to hear. A systematic review of 37 studies on weight management medications found that after stopping treatment, people regained weight at an average rate of about 0.9 pounds per month. At that pace, the math suggests a return to baseline weight roughly 1.7 years after discontinuation. Among randomized controlled trials, weight was no different between treatment and control groups about 1.4 years after stopping.
That doesn’t mean the medication was pointless. The period of lower weight can improve blood sugar control, blood pressure, joint health, and cardiovascular risk in ways that carry lasting benefits. But it does mean semaglutide works more like blood pressure medication than like a course of antibiotics. It manages an ongoing condition rather than curing it, and most people who respond well are advised to continue long-term.
Factors That Shift Your Results
Clinical trials pair medication with dietary counseling and physical activity guidance, and real-world results often depend on whether you do the same. Semaglutide is not designed to work alone. Nutrition, exercise, and behavioral changes alongside the medication are part of the standard approach recommended in current obesity management guidelines. People who treat the drug as one tool in a larger plan tend to land on the higher end of the weight-loss range.
Your starting weight plays a role too. People with more weight to lose often see larger absolute numbers on the scale, though the percentage of body weight lost tends to be fairly consistent across starting weights. Age, sex, metabolic health, sleep quality, and stress levels all nudge results in one direction or another. Two people on the same dose can have genuinely different outcomes, and neither is doing anything wrong.
If you’re not seeing at least 5% weight loss after 12 to 16 weeks on the maintenance dose, that’s generally a signal to reassess the approach with your prescriber, whether that means adjusting the dose, adding lifestyle interventions, or exploring other options.